Back to search

Article

Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6/JAK/STAT3 pathway and CSF-1 expression in dorsal root ganglion neurons

2024-03-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Janus kinase (JAK) inhibitors, such as baricitinib, are widely used to treat rheumatoid arthritis (RA). Clinical studies show that baricitinib is more effective at reducing pain than other similar drugs. Here, we aimed to elucidate the molecular mechanisms underlying the pain relief conferred by baricitinib, using a mouse model of arthritis. <bold>Methods </bold>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2cb6c2c2-5fbc-51d4-890d-5537c4c7a028
DOI
10.21203/rs.3.rs-4119106/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Baricitinib ameliorates inflammatory and neuropathic pain in collagen antibody-induced arthritis mice by modulating the IL-6/JAK/STAT3 pathway and CSF-1 expression in dorsal root ganglion neuronsDOI 10.21203/rs.3.rs-4119106/v1
Select a neighboring publication to make it the new centre.